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1. Introduction 
All the cells are engaged on a cell communication by sending and receiving signals. Cells 
having the correct receptors on their surfaces will encode the plasma membrane signal 
recognition to intracellular signals corresponding to cellular signaling events. This process 
corresponds to a huge intracellular network of protein-protein or lipid-protein interactions. 
To avoid to be lost in this kind of maze, some general signaling pathways are most of the 
time present in many cell systems such as MAP kinases or PI-3 kinases pathways. These 
signaling pathways induce some protein phosphorylation events that can be identified by 
specific antibodies directed against these phosphosites (anti-phospho antibodies). Thus, 
these crossroads can be determined by using antibodies. A widely used method to identify 
these signaling events is the Western blotting or protein immunoblotting from cell extracts. 
However, several research groups are now developing new analytical techniques based also 
on the use of anti-phospho antibodies, but allowing them to detect signaling events at the 
single cell level. These experimental approaches are using the principles of the flow 
cytometry (FCM). Phosphoflow technology will provide rapid, quantitative and also multi-
parameter analyses on single cells. 
2. Cell signaling 
In biology, cell signaling corresponds to the mechanisms of communication at the cellular 
level (Gomperts et al., 2009). The molecules involved in these exchanges provide three 
functions: transport of information via chemical signals, decoding the messages carried  
by these signals through receptors (intercellular communication itself), and finally transfer 
the orders contained in these messages to the intracellular machinery (intracellular 
communication). 
Cellular communication may be endocrine (exchange of information remotely using 
hormones), paracrine (local exchanges between adjacent cells, such as neurotransmission) or 
autocrine (messages sent and received by the same cell to self-regulate). The molecules that 
carry information (hormones, mediators) can be compared with "keys" (called ligands) 
adapted to the "locks" represented by the receivers. In this metaphor, the intracellular  
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signaling is comparable to a "bolt" activated by movement of the key in the lock. Despite 
their diversity, the signaling mechanisms are guided by common characteristics. 
2.1 General laws involved in cell signaling 
All the reactions based on a system [key-lock] and downstream events follow the law of 
mass action where molecules are engaged each other and then disengaged. These states are 
corresponding respectively to the reactions of association or dissociation. The affinity of one 
molecule for another one is defined by the ratio between association and dissociation 
constants. Thus, the affinity is high when the time of association is longer than the time of 
dissociation. These parameters are dependent of the conformational changes of the 
molecules. These alterations open some sites at the surface of the molecule that can be 
accessible, for instance, to enzymes such as the protein kinases. Thus, these opened sites 
become substrates for the kinases and a phosphate ion (PO43- ) is transferred. Thus, cell 
signaling is in part a large equilibrium between phosphorylation and dephosphorylation 
states for proteins and but also lipids. Edmond H. Fischer and Edwin G. Krebs were able to 
show that reversible protein phosphorylation affects the structure, shape, function and 
activity of proteins that are responsible for the regulation of nearly all aspects of cellular life 
(Krebs & Fischer, 1989). Fischer and Krebs received the Nobel Prize in Physiology or 
Medicine in 1992 for the discovery of reversible protein phosphorylation and its importance 
as a biological regulatory mechanism. 
2.2 Intercellular signaling 
Intercellular signaling is governed by ligand-receptor interactions. The families of ligands or 
signals often differ only by tiny molecular substitutions. The addition of a radical hydroxyl 
(-OH) or methyl (-CH3) is sufficient to differentiate the action of soluble mediators such as 
dopamine, norepinephrine and epinephrine. In the family of morphine (short sequences of 
amino acids called peptides and acting in a manner similar to morphine, especially by 
intervening in the modulation of pain), the substitution of one amino acid can alter the 
recognition by its ligand receiver called receptor. The study of immunological recognition 
provides many opportunities to demonstrate that the replacement of a few amino acids in a 
protein could markedly change binding properties. The antigen receptors such as the T-cell 
receptors (TCRs) adjust to different agonist, partial agonist and antagonist peptides by 
subtle conformational changes in their complementarity-determining regions (CDRs), in 
induced-fit mechanisms of antibody/antigen recognition (Rudolph & Wilson, 2002). This 
knowledge has been largely improved by high resolution of ligand-receptor co-crystal 
structures. Thus, various receptors recognize their ligands with different affinities. These 
differences are important because they help to refine considerably the transmission of 
information: each peptide acts optimally on its specific receptor, but is also able to affect 
other receptor family with a lower affinity. This heterogeneity of recognition generates an 
affinity gradient into the ligand-receptor interactions that in part, will explain selectivity in 
the intracellular encoding of the signals delivered by the receptors. 
2.3 Intracellular signaling 
The receptors are made up of successive sequences with the recognition motif of ligand 
(exposed to the outside of the cell), a transmembrane segment that provides the binding of 
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the receptor to the plasma membrane, and finally a sequence on intracellular enzyme 
activity. They fall into three groups that differ in the mode of intracellular as a result of the 
binding of the signal. In the simplest family (insulin receptor, for example), both ends of the 
same molecule provide signal reception and the enzyme activation. In the two other groups, 
receptor and enzyme activation functions are not contained in the same protein sequence 
such as i) a receptor directly associated with an independent cytoplasmic enzyme (for 
example, the CD4 molecule associated with the Src protein tyrosine kinase family member, 
Lck), ii) or a receptor linked to an independent cytoplasmic enzyme by a third partner 
named an adaptor protein (for example, the G protein-coupled receptor (GPCR) β 
adrenergic receptor coupled to the adenylate cyclase via heterotrimeric G proteins). 
Activation of the receptor is itself relayed by families of specialized molecules that provide 
signal transduction, that is to say their relays, the membrane to all intracellular processes 
(Fig. 1). Some of them, such as JAK (activating protein kinases called Janus, by reference to 
the Latin god of thresholds and crossings, to the extent that they "open" signaling 
downstream of receptors) (Li et al., 2008) or MAPK (mitogen-activated protein kinases) 
(Mendoza et al., 2011), integrate information from different receptors expressed at the cell 
membrane. The cell can respond appropriately, for example by phosphorylating its own 
receptors and thereby adjusting at all times the sensitivity of the cell to signals from its 
environment (the process of sensitization and desensitization). Several other main signaling 
pathways have been described such as the phosphatidylinositol 3-kinase-mammalian target 
of rapamycin (PI3K-mTOR) pathway. The signaling pathways are the major routes to control, 
for instance, cell differentiation, proliferation in response to extracellular stimuli. Moreover, 
the major pathways are playing as a concert where these pathways have common regulators 
and might intersect each other to co-regulate downstream events (Mendoza et al., 2011). 
Figure 1 illustrates a simplest view of the major signaling pathways as vertical boxes where 
always lipid or protein kinase activities are involved. Upon extracellular signals induced by 
ligand-receptor interactions, these different boxes are turned-on by some adaptor molecules 
that are connecting receptors to the first steps of these signaling cascades.  
Several websites are dedicated to describe these signaling pathways (for example, the 
Database of Cell Signaling from Science Signaling, a journal published by the American 
Association for the Advancement of Science (http://stke.sciencemag.org/) or the UCSD 
Signaling Gateway, a comprehensive resource in signal transduction (http://www.signaling- 
gateway.org/)). Some nuclear factor involved in gene transcription can be involved very 
rapidly in these signaling cascades and located transiently at the inner face of the plasma 
membrane such as the Nuclear Factor of kappa light chain gene enhancer in B cells (NFκB) 
or the Signal Transducers and Activators of Transcription (STATs). As already mentioned 
(Mendoza et al., 2011), the signaling pathways are inter-connected. For instance, the 
phosphoinositide-specific phospholipase C (PI-PLC) clives the phosphatidylinositol-4,5-
bisphosphate to generate inositol-1,4,5-trisphosphate (IP3, involved in ionized Ca2+) and 
diacylglycerol (DAG). This increase of DAG will participate to i) the activation of some 
serine/threonine protein kinase C (PKC) isoforms that are able to activate NFκB signaling 
by phosphorylating a repressor of these transcription factors (first box in Figure 1) and ii) 
the activation of the RAS / Extracellular signal-regulated kinases 1 & 2 (ERK-1/2) pathway 
via the involvement of a DAG-dependent RAS guanyl releasing protein (RasGRP) (third box 
in Figure 1). 
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Fig. 1. Some major intracellular signaling pathways activated under an exogenous triggering 
are here illustrated such as Nuclear Factor of kappa light chain gene enhancer in B cells 
(NFκB), phosphoinositide-specific phospholipase C (PI-PLC), mitogen-activated protein 
kinases (MAPK), phosphatidylinositol 3-kinase (PI3K)/Akt and Janus kinase (JAK)/ Signal 
Transducers and Activators of Transcription (STATs). These pathways are regulated by 
phosphorylation steps and inter-connected (see text). These signaling cascades are activating 
transcription factors involved in gene expression 
Thus, the intracellular signaling acts as a primary target for control of the expression of 
specific genes in the cell based on varying combinations of signals it receives. The 
intracellular signaling mechanisms involved in initiating motor responses (in muscle) or 
secretory (in the exocrine glands or the brain), but their main role is to control gene 
expression. They are thus responsible for the process of cell differentiation and a referral to a 
cell cycle proliferation or, conversely, apoptosis (programmed cell death, which led to the 
elimination of atypical cells); hence their importance in the process of tumor formation. The 
majority of cancers results from a dysfunction of intracellular signaling molecules, which in 
turn causes an imbalance between uncontrolled proliferation and loss of the ability of tumor 
cells to be self-destructed by apoptosis. 
3. Methods for the detection of signaling events 
There are several methods involving chemistry, biochemistry, microscopy and physics that 
are used to detect and analyze intracellular signals. Here, we briefly describe a general 
method used by who is interested on signal transduction as the Western blot and then we 
develop the experimental approaches using flow cytometers. 
3.1 Western blot (also called protein immunoblot): An universal method for the 
detection of signaling events  
The method is based on the use of electrophoresis to transfer proteins from a gel to a 
membrane (Towbin et al., 1979). The aim of SDS-PAGE (PolyAcrylamide Gel Electrophoresis) 
is to separate proteins according to their size, and no other physical feature. Western blots 
allow investigators to determine the molecular weight of a protein and to measure relative 
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amounts of the protein present in different samples. Prior to SDS-PAGE, the proteins should 
be extracted from isolated cells or tissues. The proteins are then transferred to a membrane 
(for example, nitrocellulose), where they are probed using specific antibodies.  
 
Fig. 2. Western blot method needs to extract the proteins from a reasonable number of cells 
(but not from a single cell) 
The signaling events are governed by phosphorylation/dephosphorylation steps. When a 
protein is phosphorylated, its apparent molecular weight will be higher (for instance, the 
molecular weight of the protein Ser/Thr kinase ERK-2 will shift from 42 to 44 kDa upon 
phosphorylation). The ERK-2 molecular weight mobility shift detected by Western blot 
correlates with an increase of ERK-2 Ser/Thr kinase activity detected by in vitro kinase 
assays (Nunès et al., 1994). However, the detection of kinase activity based on slower 
mobility of activated kinases upon SDS-PAGE is not always validated because it does 
always correlate with the real enzymatic activity (Yao et al, 2000). Thus, some specific 
antibodies have been developed against the phosphorylated peptide sequences of activated 
kinases (Yung et al., 1997). Now, many anti-phosphosite antibodies against many 
phosphorylated proteins such as protein kinases or protein kinase substrates are 
commercially available. Furthermore, the quality of these antibodies employed is of great 
importance for the success of the detection of a specific phosphorylation step. The validation 
of these antibodies will be discussed later on in the text.  
The conventional Western blot results are semi-quantitative and require a large number of 
cells (between 102 to 106 cells per point). New approaches using similar immuno-detection 
as Western blot, have been developed to reduce the number of cells per point. High-
resolution capillary isoelectric focusing (IEF) allows isoforms and individual phosphorylated 
forms to be resolved using around 25 cells per point (O’Neill et al., 2006). This capillary–
based nano-immunoassay is able evaluate the different ratio of unphosphorylated to mono 
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or bi-phosphorylated ERK1/2 using anti-ERK1/2 antibodies as a probe. This system is now 
commercialized as the NanoPro 1000 system (ProteinSimple, Santa Clara, CA, USA). Despite 
all efforts in this field of the Western blot, it is virtually impossible to reach the detection of 
signaling events at the single cell level. By definition, the flow cytometry is able to detect 
events at the single cell level using specific antibodies, which is essential in a heterogeneous 
cell population.   
3.2 Phosphoflow analysis 
Flow cytometry (FCM) has been used for a long time to detect specific markers at the cell 
surface using antibodies labeled with fluorescent dyes. Then, similar approaches have been 
performed to detect intracellular proteins such as cytokine production in hematopoietic 
cells. Intracellular cytokine detection by FCM opens the door to analyze other intracellular 
proteins such as phosphorylated signaling molecules (Chow et al., 2001; Krutzik & Nolan, 
2003). 
Detection of phospho-proteins by FCM requires that the protein is stable and accessible to 
the antibody. Cells are usually stimulated and fixed with formaldehyde or 
paraformaldehyde to cross-link the phospho-proteins and stabilize them for analysis. The 
fixed cells must then be permeabilized to allow for entry of phospho-specific antibodies into 
the cells. Different permeabilization techniques are often useful for various subcellular 
locations. A mild detergent will allow for detection of cytoplasmic proteins, while alcohol 
may be required for antibody access to nuclear proteins. Alcohol permeabilization may also 
enhance phospho-protein detection using peptide specific antibodies due to the denaturing 
property of alcohol (Krutzik et al., 2004). This approach has been improved to visualize 
many parameters at the single cell level (multidimensional molecular profiles of signaling) 
to define cell network phenotypes in many cell types (Irish et al., 2004; Irish et al., 2006).  
The consideration of signaling networks as dynamic systems is crucial for a full 
understanding, and this requires methods applicable to analyze individual living cells 
(Johnson & Hunter, 2005). A protocol has been developed to determine by FCM in a 
dynamic system and in single-cell, the phospho-protein activation status (Firaguay & 
Nunès, 2009). For this approach, a pleitropic activator of the signaling pathway such as 
pervanadate, has been used. In this protocol, the phospho-protein staining corresponds to a 
sandwich labelling to increase the brightness (for instance, a rabbit monoclonal antibody 
against anti-phosphoSer473 AKT followed by biotinylated anti-rabbit immunoglobulins (Ig) 
and then streptavidin conjuguated with the Phycoerythrin (PE).  
All the specific antibodies used for phosphoflow analysis should be well optimized for this 
technology. For instance, it will be easier to use monoclonal antibodies than polyclonal 
antibodies. These antibodies should be validated in Western blot by showing that they are 
able to detect the targeted phospho-protein at the right molecular weight (without detecting 
other protein, meaning other bands on the immunoblot). Then for a proper validation in 
FCM, the phospho-protein staining should be sensitive to the cell treatment with some 
specific inhibitors of signaling pathways (for anti-phosphoSer473 AKT staining in activated 
cells should be decreased by a cell treatment with a PI3K inhibitor). Finally, the phospho-
protein staining should be decreased or abolished in cells derived from mice invalidated for 
the gene encoding the targeted protein (KO mice) or in cellular models using a RNA 
interference. 
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Using validated anti-phospho-protein antibodies, this phosphoflow analysis is able to define 
signaling events upon receptor triggering (multi intracellular phospho-protein staining) at 
the single cell level  (multi extracellular surface marker staining). This purpose is illustrated 
in Figure 3. 
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Fig. 3. Peripheral blood mononuclear cells (PBMC) from bone marrow sample were 
obtained by Ficoll (AbCyss LymphoPrep, #1114545) gradient (centrifugation at 2500 rpm for 
20 min without brake) followed by two washes (centrifugation at 900 rpm for 15 min) in 
RPMI-1640 medium (Gibco, #21875) added to 2% Fetal Calf Serum (FCS) (Eurobio, #CVFSV 
F00-01). Cells number was determined by Trypan blue staining. Whole PBMCs were 
maintained for 16 hrs in RPMI 2% FCS at 2.105 cells/mL 
For GM-CSF stimulation, 5.105 cells were pre incubated 1 min at 37°C, and incubated with 
10 ng/mL human GM-CSF (Peprotech # 300-03) in RPMI-1640-2% FCS at 37°C for 5, 10 and 
15 min. Cells were fixed by 1,6% paraformaldehyde (PFA) (Sigma Aldrich, # 158127) at 
room temperature for 10 min. Cells were washed (centrifugation at 1800 rpm for 5 min) 
twice with phosphate-buffered saline (PBS) (Life Technologies, #70013065). Cells were 
stained 30 min at 4°C for extracellular lineage markers: CD45 - Pacific Blue (BioLegend, 
#304029), CD14 - PerCP-Cy5.5 (BD Pharmingen, #550787) and CD33 - AlexaFluor 700 (BD 
Pharmingen, #561160). After washes in FCM buffer (PBS, 2%, 1mM EDTA) viability was 
evaluated by Live/Dead Staining (Invitrogen, LIVE/DEAD Fixable Aqua Dead Cell Stain, 
#L34957) for 15 min at 4°C. Then for intracellular staining, cells were washed twice in FCM 
buffer and were permeabilized and fixed with Cytofix/Cytoperm (BD Biosciences, #554722) 
for 10 min at 37°C followed by washes in Perm/Wash buffer (BD Biosciences 10X 
Perm/Wash Buffer, #554723). Intracellular staining for phosphoflow analysis was performed 
as previously described (Firaguay & Nunès, 2009). Cells were incubated 30 min at 4°C by 
adding: i) directly coupled antibodies: anti-phospho-Akt S473 Alexa Fluor 647 (Beckman 
Coulter, #A88915), anti-phospho-ERK-1/2 T202/Y204 Alexa Fluor 488 (Beckman Coulter, 
#A88928) and ii) Uncoupled antibodies: anti-phospho-STAT5 (Cell Signaling Technology, 
#9314). Cells were wash twice in Perm/Wash buffer (BD Biosciences), incubated 20 min at 
4°C with biotinylated secondary antibodies (Jackson ImmunoResearch product, Beckman 
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Coulter, Biotin-SP-AffiniPure F(ab')2 Frag Donkey AntiRabbit IgG (H+L), #711-066-152). 
After two washes, cells were incubated 15 min at 4°C with Streptavidin conjugated with 
phycoerythrin (Streptavidin-PE) (Beckman Coulter, #IM3325). Cells were washed twice, re-
suspended in PBS and processed on a LSR II SORP 4 lasers flow cytometer (BD Becton 
Dickinson). Data were collected and analyzed using DIVA software (BD Biosciences) and 
FlowJo software (Tree Star). 
Panel A: Monocyte gating strategy. Monocytes were gated on i) intermediate Side scatter 
cells and CD45 positive cells and then ii) on both CD14 and CD33 positive cells. Then 
phospho-Erk, phospho-Akt and phospho-Stat5 were visualized on the monocyte population 
in resting condition and under 10 ng/mL of human GM-CSF stimulation for different times 
(5, 10 and 15 min). For this illustration, dot plots were analyzed using DIVA software (BD 
Biosciences). 
Panel B: AKT, ERK1/2 and Stat5 phosphorylation kinetics in monocytes under GM-CSF 
stimulation. Kinetics Ratio (stimulated / non treated NT) Mean (left) and Median (right) of 
fluorescence in response to 10 ng/mL human GM-CSF stimulation. As represented, kinetics 
are similar on both Mean and Median Fluorescence intensity parameters: phospho-Stat5 and 
phospho-ERK1/2 increase are early: at 5 min of stimulation and they decreased to a constant 
“sub-basal” level at 10 min, whereas phospho-AKT is increased later: at 10 min of 
stimulation and decreased at 15 min. For this representation statistical data were extracted 
using FlowJo software (Tree Star). 
Panel C: Statistical representation of phospho-AKT, ERK1/2 and Stat5 negative and 
positive monocytes populations under GM-CSF stimulation. Color gradation represents 
percentages of monocytes negative for phospho-ERK1/2, phospho-AKT and phospho-Stat5 
(in white), positive for one and two of these parameters (respectively in light and dark grey) 
and positive for all of them (in black). Colored curves surrounding circles shows positive 
phospho-proteins represented in each portion of the circle: phospho-ERK1/2, phospho-AKT 
and phospho-Stat5 are respectively in yellow, red and green. As represented, phopho-Stat5 
alone and associated to phospho-ERK alone or with phospho-AKT is the major signaling 
response of monocytes to GM-CSF stimulation, in particular at 5 min. Phospho-AKT 
response to stimulation appears to be later since at 10 min the percentage of phospho-AKT 
positive monocytes is distinctly increased, in particular for proportion only phospho-AKT 
positive cells at this time of stimulation. For this representation, statistical data were 
extracted using FlowJo software (Tree Star) and represented with SPICE v5.2 software 
(Apple Mac U.C. Berkeley, CA, USA). 
4. Concluding remarks and recent investigations in phosphoflow analysis 
As illustrated by data shown in Figure 3, the phosphoflow analysis permits to use one or 
multiple signal transduction markers in association with cell surface markers to dissect 
complex biological processes in heterogeneous populations. This technique is quite rapid, 
quantitative and a major point: working at the single cell level. However, the investigators 
must be careful with the buffers used for cell fixation and permeabilization that could affect 
the binding of the antibodies to the phosphosites (Krutzik et al., 2004). Another major point 
is a perfect validation of the antibodies used for phosphoflow analysis (see text, paragraph 
3.2). In some case, the brightness of a signaling marker will be enhanced by using a 
sandwich labeling method (Firaguay & Nunès, 2009).   
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The ability to analyze multiple single-cell parameters is critical for understanding cellular 
heterogeneity. In the context of oncology, cancer cells harboring a hyperactivation of 
signaling pathways such PI3K/AKT, Ras/ERK or JAK/Stats pathways can be treated with 
specific inhibitors of these pathways (Vivanco & Sawyers, 2002; Irish et al., 2006).  However, 
such inhibitors will target the cancer cells but can also affect other cell types that will be 
involved in the tumor environment (Le Tourneau et al., 2008). Thus, these chemotherapy 
protocols could affect the homeostasis of the normal cell compartment that could be 
evaluated by analyzing multiple single-cell parameters. This balance is illustrated by a 
picture into the Figure 4 (see below). 
 
Fig. 4. By targeting Ras/ERK or PI3K/AKT pathways in cancer cells, these treatments could 
affect for instance immune cells such as Natural Killer (NK) cells or different T cell subsets 
such as regulatory T cells (Tregs). This cell homeostasis will be affected as illustrated by this 
picture as a Mikado game where sticks could be a signaling parameter or a cell type. The 
artwork of this picture has been performed by the STUDIO HULKETTE 
(http://www.hulkette.com) 
To analyze a large number of parameters at the single cell level in a heterogeneous 
population, new apparatus has been developed by Scott Tanner’s group, the single-cell mass 
cytometer (Bandura et al., 2009). In this study, single cell 20 antigen expression assay was 
performed on cell lines and leukemia patient samples immuno-labeled with lanthanide-
tagged antibodies. Recent studies from Gary Nolan’s group push this technology to analyze 
simultaneously 34 cellular parameters, where they compare the consequences of different 
drug treatments on the immune cells and hematopoiesis (Bendall et al., 2011). The beauty of 
 
Analysis of Cellular Signaling Events by Flow Cytometry 
 
335 
these new technologies in the field of cell signaling opens a new area on the signal 
monitoring of treatments in many diseases such as cancers, infectious or autoimmune 
diseases. However, a brake to the development of these approaches will be the huge number 
of data that will be generated and how to analyze these data. Some clues of computational 
approaches were already built such as spanning-tree progression analysis of density-
normalized events (SPADE) (Qiu et al., 2011).  
Phosphoflow analysis will become an universal technology to investigate cell signaling 
events at the single cell level. By using validated antibodies for FCM and right protocols of 
fixation/permeabilization, the phosphoflow analysis will be a standard method in many 
labs across the world to analyze few parameters at the same time. Moreover, the new 
technologies are already under the market to analyze more than 30 parameters at the same 
time. 
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